Anti PD-1/PD-L1 Immune checkpoint inhibitors - addition - EML and EMLc

被引:0
|
作者
机构
关键词
CELL LUNG-CANCER; OPEN-LABEL PHASE-3; ADVANCED MELANOMA; COST-EFFECTIVENESS; PEMBROLIZUMAB; NIVOLUMAB; CHEMOTHERAPY; IPILIMUMAB; DOCETAXEL; MULTICENTER;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:314 / 331
页数:18
相关论文
共 50 条
  • [31] Adverse cutaneous toxicities by PD-1/PD-L1 immune checkpoint inhibitors: pathogenesis, treatment, and surveillance
    Bhardwaj, Maitry
    Chiu, Mei Nee
    Sah, Sangeeta Pilkhwal
    CUTANEOUS AND OCULAR TOXICOLOGY, 2022, 41 (01) : 73 - 90
  • [32] PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy
    Dermani, Fatemeh K.
    Samadi, Pouria
    Rahmani, Golebagh
    Kohlan, Alisa K.
    Najafi, Rezvan
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (02) : 1313 - 1325
  • [33] The Roles of microRNAs in Regulating the Expression of PD-1/PD-L1 Immune Checkpoint
    Wang, Qingshui
    Lin, Wei
    Tang, Xiaoqiong
    Li, Suhuan
    Guo, Libin
    Lin, Yao
    Kwok, Hang Fai
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (12)
  • [34] Immunohistochemistry of Immune Checkpoint Markers PD-1 and PD-L1 in Prostate Cancer
    Sharma, Meenal
    Yang, Qi
    Mcmahon, Loralee
    Miyamoto, Hiroshi
    MODERN PATHOLOGY, 2019, 32
  • [35] Small-Molecule Immune Checkpoint Inhibitors Targeting PD-1/PD-L1 and Other Emerging Checkpoint Pathways
    Pottayil G. Sasikumar
    Murali Ramachandra
    BioDrugs, 2018, 32 : 481 - 497
  • [36] Small-Molecule Immune Checkpoint Inhibitors Targeting PD-1/PD-L1 and Other Emerging Checkpoint Pathways
    Sasikumar, Pottayil G.
    Ramachandra, Murali
    BIODRUGS, 2018, 32 (05) : 481 - 497
  • [37] Phytochemicals in regulating PD-1/PD-L1 and immune checkpoint blockade therapy
    Zhang, Qi
    Yang, Chenying
    Gao, Xingsu
    Dong, Ju
    Zhong, Caiyun
    PHYTOTHERAPY RESEARCH, 2024, 38 (02) : 776 - 796
  • [38] Immunohistochemistry of Immune Checkpoint Markers PD-1 and PD-L1 in Prostate Cancer
    Sharma, Meenal
    Yang, Qi
    Mcmahon, Loralee
    Miyamoto, Hiroshi
    LABORATORY INVESTIGATION, 2019, 99
  • [39] PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
    Hartkopf, Andreas D.
    Taran, Florin-Andrei
    Wallwiener, Markus
    Walter, Christina B.
    Kraemer, Bernhard
    Grischke, Eva-Maria
    Brucker, Sara Y.
    BREAST CARE, 2016, 11 (06) : 385 - 390
  • [40] Immunohistochemistry of immune checkpoint markers PD-1 and PD-L1 in prostate cancer
    Sharma, Meenal
    Yang, Zhiming
    Miyamoto, Hiroshi
    MEDICINE, 2019, 98 (38)